var dataLayer = {}; var digitalData = {}; -->

Explore Crisil, a company of S&P Global

Formerly known as Global Research & Risk Solutions

End-to-end support across the investment life cycle

US-based private market General Partner (GP); AUM: $80+ bn

Requirement
 

  • Expand the private equity portfolio through a cost-effective model

Challenges faced by the client
 

  • Limited bandwidth across departments
  • Constrained value creation capabilities
  • Availability of data analytics talent

CRISIL solution

Investment research and portfolio support
 

  • 20 FTEs research support on target identification, due diligence, incl. financial modeling, portfolio monitoring
  • Support across Tech, Healthcare/Life Sciences, Financial Services, Renewables and Consumer sectors
  • Provides recommendations to investment committee 
  • 8 FTEs supporting active portfolio value creation

Data intelligence support
 

  • 2 FTEs to support on data and build analytical insights
  • Design pricing strategies and built investor networks

Marketing collaterals support
 

  • Produce sector-focused primers, insights, newsletters

CRISIL impact

Benefits to the client
 

  • Optimize onshore bandwidth
  • Expand the global portfolio by 2x and AUM by 3x
  • Flexible scaling of team to service peak deal cycles
  • Operations cost saving of ~50%

 

 

Questions

Looking for high-end research and risk services? Reach out to us at:
 

United States
1-855-595-2100/
+1 646 292 3520

 

United Kingdom
+44 (0) 870 333 6336

India
+91 22 33 42 3000 /
+91 22 61 72 3000